Secondhand Smoke Exposure Linked to Odds of ADHD Symptoms
Exposure to secondhand smoke (SHS) from pregnancy to childhood is associated with increased odds of having attention-deficit/hyperactivity disorder (ADHD) symptoms and subtypes, according to a study published online May 20 in JAMA Network Open.
Read MoreHow Do You Help a Sluggish Child?
KEY POINTS: Problems with attention problems, mind-wandering, and energy have led to the controversial construct Sluggish Cognitive Tempo (SCT). There is debate as to whether this condition is part of ADHD or a distinct diagnosis. No medications are currently approved to treat SCT. Potentially relevant drugs may include Strattera, Ritalin, and antidepressants.
Read MoreHow to Recall Coping Skills for Adult ADHD
KEY POINTS: Many adults with ADHD struggle to remember to use coping skills at the point of performance, when they are needed most. Catchy reminders or mantras, such as “count to 10,” are useful tools to help activate coping strategies or at least to recall coping options. A five-step list for adults with ADHD serves…
Read MoreDiagnosing ADHD in the Future: Sweeping Away Old Concepts
KEY POINTS: ADHD is defined by clinical characteristics, as there are no definitive other tests. There should be new criteria that reflect changing ideas about ADHD like considering the context of electronic distractions and comorbidities. Family history should always be part of the assessment.
Read MoreGovernment urged to give ADHD patients branded medication
Calls for Concerta medication grow amid reports of Xenidate side effects…Patients with ADHD (Attention Deficit Hyperactivity Disorder) and psychiatrists are once again calling on the government [of Malta] to revert to branded medication as the current treatment is having a detrimental effect on some children and adults.
Read MoreViloxazine Is a New Option to Treat ADHD in Children
Nonstimulants are also recommended for those that do not see the full benefit from stimulant medications…Vviloxazine (Qelbree), is a new treatment option, approved in the United States in April 2021. This drug is a norepinephrine reuptake inhibitor indicated for patients aged 6 to 17 years.
Read MoreStudy: Children with autism or ADHD can mask consistently
Children with autism spectrum disorder or attention-deficit/hyperactivity disorder participating in a summer treatment program were able to wear face coverings effectively, researchers at the University of Washington School of Medicine in Seattle report today in JAMA Network Open.
Read MoreWhat to know about exercise and ADHD
Both cardiovascular and noncardiovascular exercise show some promise as treatments for ADHD symptoms. However, regular exercise does not automatically mean that a person will see improvements in all aspects of the condition. In this article, we look at whether exercise can help with ADHD. We also explain how often people should exercise and suggest some…
Read MoreBreathing exercises improve focus in children with ADHD
Yoga and breathing exercises can improve attention and decrease hyperactivity in children with attention deficit hyperactivity disorder (ADHD). A team of psychologists at Ural Federal University also found that after special exercise training, children with ADHD could engage in complex activities for longer without getting tired.
Read MoreHigher ADHD Treatment Adherence Rates Linked to Text Message Intervention
A team, led by Joseph Biederman, MD, Massachusetts General Hospital, examined if text message reminders could be effective in adherence to ADHD stimulant medications in both children and adults. The findings were presented at the American Psychiatric Association Annual Meeting.
Read MoreUncertainty Intolerance Higher in Outpatients with ADHD
Adult psychiatric outpatients with attention-deficit/hyperactivity disorder (ADHD) had higher levels of uncertainty intolerance compared with outpatients without ADHD, according to a poster presented at the virtual 2021 American Psychiatric Association Annual Meeting.
Read MoreLate-breaking news on trajectory of ADHD remission headlines world conference
Most patients will not make a full recovery from attention-deficit/hyperactivity disorder in adulthood. This late-breaking finding headlined the World Congress on ADHD – Virtual Event. Held under the specter of SARS-CoV-2, the virtual program delved into the latest research on ADHD pathophysiology, imaging, genetics, and issues on medical and psychiatric comorbidities. However, one of the…
Read More